Article thumbnail

Quantification of phosphorylated metabolites based on <sup>31</sup>P spectra for different tissue samples and experimental groups.

By Rui V. Simões (126313), Miquel E. Cabañas (6160655), Carla Loreiro (6160658), Miriam Illa (185342), Fatima Crispi (373448) and Eduard Gratacós (3128295)

Abstract

<p>Values displayed as metabolite peak areas normalized to sample weight (average ±SD) for brain (<b>A</b>) and heart (<b>B</b>) samples of CTR, GLC and ACE groups. PC could not be quantified properly in heart samples due to overlap with 2,3-diphosphoglycerate (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0208784#pone.0208784.g005" target="_blank">Fig 5</a>). Significant differences between AGA and FGR subjects are indicated (* p<0.05, two-tailed unpaired t-Test).</p

Topics: Biochemistry, Medicine, Cell Biology, Molecular Biology, Physiology, Developmental Biology, Cancer, Computational Biology, AGA, Lac C 2C, 13 C-labelled substrate infusions, term FGR fetuses, gestation, 2 D spectra, cell membrane turnover, rabbit model, growth restriction, New Zealand rabbits, heart apex regions, metabolism, vivo multinuclear HRMAS Background, phospholipid breakdown products, non-infused control hearts, multinuclear 1 D
Year: 2018
DOI identifier: 10.1371/journal.pone.0208784.g006
OAI identifier: oai:figshare.com:article/7527176
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.plosone.org/article... (external link)
  • https://figshare.com/articles/... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.